Liposomal Doxorubicin Market - Global Outlook and Forecast 2021-2027

Code: RW00014517807
Market Monitor Global
Sep-2021
Life Sciences
92 Pages

This report contains market size and forecasts of Liposomal Doxorubicin in global, including the following market information:
Global Liposomal Doxorubicin Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Liposomal Doxorubicin Market Sales, 2016-2021, 2022-2027, (K Unit)
Global top five Liposomal Doxorubicin companies in 2020 (%)
The global Liposomal Doxorubicin market was valued at 1217.9 million in 2020 and is projected to reach US$ 1618.5 million by 2027, at a CAGR of 7.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomal Doxorubicin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomal Doxorubicin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Unit)
Global Liposomal Doxorubicin Market Segment Percentages, By Type, 2020 (%)
5 ml
10 ml
25 ml

Global Liposomal Doxorubicin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Unit)
Global Liposomal Doxorubicin Market Segment Percentages, By Application, 2020 (%)
Breast Cancer
Liver Cancer
Kidney Cancer
Multiple Myeloma
Ovarian Cancer
Other

Global Liposomal Doxorubicin Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Unit)
Global Liposomal Doxorubicin Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomal Doxorubicin revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Liposomal Doxorubicin revenues share in global market, 2020 (%)
Key companies Liposomal Doxorubicin sales in global market, 2016-2021 (Estimated), (K Unit)
Key companies Liposomal Doxorubicin sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Liposomal Doxorubicin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomal Doxorubicin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomal Doxorubicin Overall Market Size
2.1 Global Liposomal Doxorubicin Market Size: 2021 VS 2027
2.2 Global Liposomal Doxorubicin Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Liposomal Doxorubicin Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Liposomal Doxorubicin Players in Global Market
3.2 Top Global Liposomal Doxorubicin Companies Ranked by Revenue
3.3 Global Liposomal Doxorubicin Revenue by Companies
3.4 Global Liposomal Doxorubicin Sales by Companies
3.5 Global Liposomal Doxorubicin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Liposomal Doxorubicin Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Liposomal Doxorubicin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomal Doxorubicin Players in Global Market
3.8.1 List of Global Tier 1 Liposomal Doxorubicin Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposomal Doxorubicin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Liposomal Doxorubicin Market Size Markets, 2021 & 2027
4.1.2 5 ml
4.1.3 10 ml
4.1.4 25 ml
4.2 By Type - Global Liposomal Doxorubicin Revenue & Forecasts
4.2.1 By Type - Global Liposomal Doxorubicin Revenue, 2016-2021
4.2.2 By Type - Global Liposomal Doxorubicin Revenue, 2022-2027
4.2.3 By Type - Global Liposomal Doxorubicin Revenue Market Share, 2016-2027
4.3 By Type - Global Liposomal Doxorubicin Sales & Forecasts
4.3.1 By Type - Global Liposomal Doxorubicin Sales, 2016-2021
4.3.2 By Type - Global Liposomal Doxorubicin Sales, 2022-2027
4.3.3 By Type - Global Liposomal Doxorubicin Sales Market Share, 2016-2027
4.4 By Type - Global Liposomal Doxorubicin Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposomal Doxorubicin Market Size, 2021 & 2027
5.1.2 Breast Cancer
5.1.3 Liver Cancer
5.1.4 Kidney Cancer
5.1.5 Multiple Myeloma
5.1.6 Ovarian Cancer
5.1.7 Other
5.2 By Application - Global Liposomal Doxorubicin Revenue & Forecasts
5.2.1 By Application - Global Liposomal Doxorubicin Revenue, 2016-2021
5.2.2 By Application - Global Liposomal Doxorubicin Revenue, 2022-2027
5.2.3 By Application - Global Liposomal Doxorubicin Revenue Market Share, 2016-2027
5.3 By Application - Global Liposomal Doxorubicin Sales & Forecasts
5.3.1 By Application - Global Liposomal Doxorubicin Sales, 2016-2021
5.3.2 By Application - Global Liposomal Doxorubicin Sales, 2022-2027
5.3.3 By Application - Global Liposomal Doxorubicin Sales Market Share, 2016-2027
5.4 By Application - Global Liposomal Doxorubicin Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Liposomal Doxorubicin Market Size, 2021 & 2027
6.2 By Region - Global Liposomal Doxorubicin Revenue & Forecasts
6.2.1 By Region - Global Liposomal Doxorubicin Revenue, 2016-2021
6.2.2 By Region - Global Liposomal Doxorubicin Revenue, 2022-2027
6.2.3 By Region - Global Liposomal Doxorubicin Revenue Market Share, 2016-2027
6.3 By Region - Global Liposomal Doxorubicin Sales & Forecasts
6.3.1 By Region - Global Liposomal Doxorubicin Sales, 2016-2021
6.3.2 By Region - Global Liposomal Doxorubicin Sales, 2022-2027
6.3.3 By Region - Global Liposomal Doxorubicin Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Liposomal Doxorubicin Revenue, 2016-2027
6.4.2 By Country - North America Liposomal Doxorubicin Sales, 2016-2027
6.4.3 US Liposomal Doxorubicin Market Size, 2016-2027
6.4.4 Canada Liposomal Doxorubicin Market Size, 2016-2027
6.4.5 Mexico Liposomal Doxorubicin Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Liposomal Doxorubicin Revenue, 2016-2027
6.5.2 By Country - Europe Liposomal Doxorubicin Sales, 2016-2027
6.5.3 Germany Liposomal Doxorubicin Market Size, 2016-2027
6.5.4 France Liposomal Doxorubicin Market Size, 2016-2027
6.5.5 U.K. Liposomal Doxorubicin Market Size, 2016-2027
6.5.6 Italy Liposomal Doxorubicin Market Size, 2016-2027
6.5.7 Russia Liposomal Doxorubicin Market Size, 2016-2027
6.5.8 Nordic Countries Liposomal Doxorubicin Market Size, 2016-2027
6.5.9 Benelux Liposomal Doxorubicin Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Liposomal Doxorubicin Revenue, 2016-2027
6.6.2 By Region - Asia Liposomal Doxorubicin Sales, 2016-2027
6.6.3 China Liposomal Doxorubicin Market Size, 2016-2027
6.6.4 Japan Liposomal Doxorubicin Market Size, 2016-2027
6.6.5 South Korea Liposomal Doxorubicin Market Size, 2016-2027
6.6.6 Southeast Asia Liposomal Doxorubicin Market Size, 2016-2027
6.6.7 India Liposomal Doxorubicin Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Liposomal Doxorubicin Revenue, 2016-2027
6.7.2 By Country - South America Liposomal Doxorubicin Sales, 2016-2027
6.7.3 Brazil Liposomal Doxorubicin Market Size, 2016-2027
6.7.4 Argentina Liposomal Doxorubicin Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liposomal Doxorubicin Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Liposomal Doxorubicin Sales, 2016-2027
6.8.3 Turkey Liposomal Doxorubicin Market Size, 2016-2027
6.8.4 Israel Liposomal Doxorubicin Market Size, 2016-2027
6.8.5 Saudi Arabia Liposomal Doxorubicin Market Size, 2016-2027
6.8.6 UAE Liposomal Doxorubicin Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Liposomal Doxorubicin Major Product Offerings
7.1.4 Johnson & Johnson Liposomal Doxorubicin Sales and Revenue in Global (2016-2021)
7.1.5 Johnson & Johnson Key News
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Corporate Summary
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Liposomal Doxorubicin Major Product Offerings
7.2.4 Sun Pharmaceutical Liposomal Doxorubicin Sales and Revenue in Global (2016-2021)
7.2.5 Sun Pharmaceutical Key News
7.3 CSPC
7.3.1 CSPC Corporate Summary
7.3.2 CSPC Business Overview
7.3.3 CSPC Liposomal Doxorubicin Major Product Offerings
7.3.4 CSPC Liposomal Doxorubicin Sales and Revenue in Global (2016-2021)
7.3.5 CSPC Key News
7.4 Kinyond
7.4.1 Kinyond Corporate Summary
7.4.2 Kinyond Business Overview
7.4.3 Kinyond Liposomal Doxorubicin Major Product Offerings
7.4.4 Kinyond Liposomal Doxorubicin Sales and Revenue in Global (2016-2021)
7.4.5 Kinyond Key News
7.5 Teva
7.5.1 Teva Corporate Summary
7.5.2 Teva Business Overview
7.5.3 Teva Liposomal Doxorubicin Major Product Offerings
7.5.4 Teva Liposomal Doxorubicin Sales and Revenue in Global (2016-2021)
7.5.5 Teva Key News
7.6 Fudan-Zhangjiang
7.6.1 Fudan-Zhangjiang Corporate Summary
7.6.2 Fudan-Zhangjiang Business Overview
7.6.3 Fudan-Zhangjiang Liposomal Doxorubicin Major Product Offerings
7.6.4 Fudan-Zhangjiang Liposomal Doxorubicin Sales and Revenue in Global (2016-2021)
7.6.5 Fudan-Zhangjiang Key News
7.7 Zydus Cadila
7.7.1 Zydus Cadila Corporate Summary
7.7.2 Zydus Cadila Business Overview
7.7.3 Zydus Cadila Liposomal Doxorubicin Major Product Offerings
7.4.4 Zydus Cadila Liposomal Doxorubicin Sales and Revenue in Global (2016-2021)
7.7.5 Zydus Cadila Key News
7.8 TTY Biopharma
7.8.1 TTY Biopharma Corporate Summary
7.8.2 TTY Biopharma Business Overview
7.8.3 TTY Biopharma Liposomal Doxorubicin Major Product Offerings
7.8.4 TTY Biopharma Liposomal Doxorubicin Sales and Revenue in Global (2016-2021)
7.8.5 TTY Biopharma Key News
8 Global Liposomal Doxorubicin Production Capacity, Analysis
8.1 Global Liposomal Doxorubicin Production Capacity, 2016-2027
8.2 Liposomal Doxorubicin Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomal Doxorubicin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liposomal Doxorubicin Supply Chain Analysis
10.1 Liposomal Doxorubicin Industry Value Chain
10.2 Liposomal Doxorubicin Upstream Market
10.3 Liposomal Doxorubicin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposomal Doxorubicin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Liposomal Doxorubicin in Global Market
Table 2. Top Liposomal Doxorubicin Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Liposomal Doxorubicin Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Liposomal Doxorubicin Revenue Share by Companies, 2016-2021
Table 5. Global Liposomal Doxorubicin Sales by Companies, (K Unit), 2016-2021
Table 6. Global Liposomal Doxorubicin Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Liposomal Doxorubicin Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Liposomal Doxorubicin Product Type
Table 9. List of Global Tier 1 Liposomal Doxorubicin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomal Doxorubicin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE